About BioMed Central
BioMed Central is a company based in London (United Kingdom) founded in 2000 by Ayanna Anene, and was acquired by Springer in October 2008. It operates as an open-access journals in biology, health, and medicine are published. Its chief executive is Etienne Boue. Its website biomedcentral.com draws about 455 thousand monthly visits. BioMed Central offers products and services including Open Access Journals and Data Sharing Services. Its legal entity is BioMed Central Ltd.
Company details
BioMed Central was founded in 2000 and is headquartered in London, United Kingdom. Operations focus on open-access publishing within the scientific sector, particularly biology, health sciences, and medicine. A portfolio of journals is maintained to enable researchers to share work through peer-reviewed processes. Author support is provided, including advice on funding and data sharing. Transparency in publishing and open data practices are emphasized across activities.
- Headquarters London, United Kingdom
- Founders Ayanna Anene
- Stage Acquired
- Website category Science and Education · Biology
- Email••••••••
- Website biomedcentral.com
- Social LinkedIn X Facebook
- Acquired by Springer (Oct 2008)
- Legal Name Biomed Central Ltd
- Annual Revenue$119.4 K (USD)15as on Dec 31, 2022
- Net Profit$37.33 K (USD)0as on Dec 31, 2022
- InvestorsFortress Investment
& 3 more
- Acquired bySpringer
(Oct 2008)
Products & Services of BioMed Central
BioMed Central offers a comprehensive portfolio of products and services, including Open Access Journals and Data Sharing Services.
Research in biology and medicine is published through these journals
Data sharing and open access practices are supported to advance research in health sciences
Funding Insights of BioMed Central
- Total Rounds 5
- First Round $318,592
(Sep 2009)
- Investors Count 3
All 5 funding rounds of BioMed Central with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2018 | – | Grant | – | – | |
| Jan 2017 | $9,000 | Grant | – | – | |
| Jun 2015 | – | Grant | – | – | |
| Jan 2014 | – | Grant | – | – | |
| Sep 2009 | $318,592 | Grant | – | – |
4 investors in total: 4 institutional.
Investors in BioMed Central
BioMed Central has secured backing from 4 investors, including institutional investors. Prominent investors backing the company include Fortress Investment, HHS and Springer.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of credit, private equity, and capital investment services | 1998 | fortress.com | Atlanta, United States | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - | |
Scientific, technical, and medical literature is published globally by Springer. | 1842 | springer.com | Heidelberg, Germany |
Investor details for BioMed Central
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of BioMed Central
3 people are tracked at BioMed Central (3 in leadership).
| Name | Role | Group |
|---|---|---|
Ayanna Anene | Founder | Leadership |
Etienne Boue | CEO | Leadership |
Lin Lee | Chief Editor | Leadership |
Complete people profiles for BioMed Central
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of BioMed Central
4 dated milestones of BioMed Central across 18 years, from founding to its latest funding, stage changes and deals.
- Founded BioMed Central is founded.
- Exit Acquired by Springer.
- Funding First funding round of $319K.
- Funding Latest funding round, Grant,.
Web traffic of BioMed Central
The website of BioMed Central (biomedcentral.com) receives about 455K visits a month and ranks #67,427 among all websites worldwide, #4,225 in Biology.
- Monthly visits455K
▼ 52.5% vs previous month
- Unique visitors482.2K
per month
- Global rank#67,427
among all websites
- Category rank#4,225
Science and Education · Biology
- Bounce rate58%
- Pages per visit1.8
- Average visit34 sec
- DevicesDesktop 18% · Mobile 82%
Websites whose visitors overlap most with BioMed Central. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| nature.com | 100% | 33.6M | #1,922 | View details | |
| frontiersin.org | 86% | 11.4M | #6,155 | View details | |
| cell.com | 79% | 5M | #14,619 | View details | |
| europepmc.org | 74% | – | #53,748 | View details | |
| biorxiv.org | 70% | 3M | #19,954 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for BioMed Central
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Biomed Central
Complete news archive for BioMed Central
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioMed Central
BioMed Central was founded in 2000 and raised its 1st funding round 9 years after it was founded.
BioMed Central is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Etienne Boue is the current CEO of BioMed Central.
Annual revenue of BioMed Central is $119.4K as on Dec 31, 2022.
BioMed Central was founded in 2000 and is headquartered in London, United Kingdom. Operations focus on open-access publishing within the scientific sector, particularly biology, health sciences, and medicine. A portfolio of journals is maintained to enable researchers to share work through peer-reviewed processes. Author support is provided, including advice on funding and data sharing. Transparency in publishing and open data practices are emphasized across activities.
BioMed Central offers Open Access Journals and Data Sharing Services.
BioMed Central has 4 investors. Key investors include Fortress Investment, HHS, Springer, and European Union.
BioMed Central operates through Biomed Central Ltd.
Yes. BioMed Central was acquired by Springer in October 2008.
The website of BioMed Central receives about 455 thousand visits a month and ranks #67,427 among all websites worldwide.